Scott M Turner

Emerging applications of kinetic biomarkers in preclinical and clinical drug development.

Scott M Turner, Marc K Hellerstein, S. Turner, 2005, Current opinion in drug discovery & development.

Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis[S]

Scott M Turner, H. Ogata, J. Maher, 2009, Journal of Lipid Research.

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib.

Naveen Garg, Dominik Wodarz, Xuelin Huang, 2017, JCI insight.